Literature DB >> 3133755

Strategies of Pseudomonas aeruginosa to colonize and to persist in the cystic fibrosis lung.

P Kubesch1, M Lingner, D Grothues, M Wehsling, B Tümmler.   

Abstract

The early stage of the colonization of Pseudomonas aeruginosa in cystic fibrosis (CF) was investigated. Most CF patients, once they have become colonized, harboured genomically related P. aeruginosa strains in their respiratory tract over long periods. Unrelated CF patients were colonized with different strains; however, within families cross-infection between CF siblings frequently took place. Adherence tests with buccal epithelial cells demonstrated that the epithelial cell layer of the oropharynx remained intact for up to 2 years after the onset of colonization with P. aeruginosa. Among the constituents of the microcolony the bronchial mucins were determined to be the major binding targets of CF isolates of P. aeruginosa. The time course of antibody formation to outer membrane antigens of P. aeruginosa in CF serum was analysed by Western immunoblots. Lipopolysaccharide and protein H induced the first systemic immune response.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3133755

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN: 0085-5928


  5 in total

Review 1.  Infection control in cystic fibrosis: methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa and the Burkholderia cepacia complex.

Authors:  J R Govan
Journal:  J R Soc Med       Date:  2000       Impact factor: 5.344

2.  Treatment of pseudomonas aeruginosa colonisation in cystic fibrosis.

Authors:  G Steinkamp; B Tümmler; R Malottke; H von der Hardt
Journal:  Arch Dis Child       Date:  1989-07       Impact factor: 3.791

3.  Mucosal and systemic antibody responses to potential Pseudomonas aeruginosa vaccine protein antigens in young children with cystic fibrosis following colonization and infection.

Authors:  Ryka Moore; Jennelle M Kyd; Rosemary Carzino; Davide Armstrong; Keith Grimwood; Diana C Otczyk; Allan W Cripps
Journal:  Hum Vaccin Immunother       Date:  2012-12-18       Impact factor: 3.452

4.  Fimbriation of Pseudomonas cepacia.

Authors:  M Kuehn; K Lent; J Haas; J Hagenzieker; M Cervin; A L Smith
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

5.  Suppression of lymphocyte and neutrophil functions by Pseudomonas aeruginosa mucoid exopolysaccharide (alginate): reversal by physicochemical, alginase, and specific monoclonal antibody treatments.

Authors:  G T Mai; W K Seow; G B Pier; J G McCormack; Y H Thong
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.